Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Subject:   I'm Interested in Participating in Your Clinical Trial

Message:   Dear Investigator,

Comment:  

Thanks,